Medicon Hellas S.A. Logo

Medicon Hellas S.A.

MEDIC | AT

Overview

Corporate Details

ISIN(s):
GRS424003002
LEI:
21380029I4NIQ9ZXE146
Country:
Greece
Address:
MELITONA 5-7, 15344 GERAKAS
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Medicon Hellas S.A. is a leading company in the in-vitro diagnostics (IVD) sector. Its operations encompass the research, development, manufacturing, and sale of proprietary IVD products, including diagnostic reagent kits and bulk materials. The company also imports and distributes automated analytical systems from international manufacturers and develops specialized software for laboratory and medical applications. It serves a broad range of healthcare providers, such as public and private hospitals, clinical labs, and diagnostic centers. Products are exported globally through a network of distributors as both branded items and materials for further processing. The company's activities also include providing diagnostic services and manufacturing a line of cosmetics and personal care products. Medicon Hellas operates under key quality certifications, including ISO 13485, and a manufacturer’s license from the National Medicines Organization.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Medicon Hellas S.A.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-06-26 09:11
Notice of Dividend Amount
ΟΡΘΗ ΕΠΑΝΑΛΗΨΗ-ΓΝΩΣΤΟΠΟΙΗΣΗ ΑΠΟΚΟΠΗΣ ΔΙΚΑΙΩΜΑΤΟΣ ΜΕΡΙΣΜΑΤΟΣ / ΠΛΗΡΩΜΗΣ ΜΕΡΙΣΜΑΤ…
Greek (modern) 800.1 KB
2025-06-26 09:10
Declaration of Voting Results & Voting Rights Announcements
ΟΡΘΗ ΕΠΑΝΑΛΗΨΗ-ΑΝΑΚΟΙΝΩΣΗ ΓΙΑ ΤΙΣ ΑΠΟΦΑΣΕΙΣ ΓΕΝΙΚΗΣ ΣΥΝΕΛΕΥΣΗΣ
Greek (modern) 518.3 KB
2025-06-25 16:42
Declaration of Voting Results & Voting Rights Announcements
ΑΝΑΚΟΙΝΩΣΗ ΓΙΑ ΤΙΣ ΑΠΟΦΑΣΕΙΣ ΓΕΝΙΚΗΣ ΣΥΝΕΛΕΥΣΗΣ
Greek (modern) 518.2 KB
2025-05-30 11:14
Pre-Annual General Meeting Information
INVITATION FOR THE ANNUAL GENERAL MEETING 2025
English 490.8 KB

Automate Your Workflow. Get a real-time feed of all Medicon Hellas S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Medicon Hellas S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Otsuka Holdings Co., Ltd. Logo Japan 4578
Oxford Biomedica PLC Logo
A CDMO for cell & gene therapy, providing end-to-end viral vector development & manufacturing.
United Kingdom OXB
PAION AG Logo
Developed innovative drugs for hospital sedation, anesthesia, and critical care.
Germany PA8
PeptiDream Inc. Logo Japan 4587
PEPTONIC Medical AB Logo
Develops clinically proven self-care products and diagnostics for women's intimate health.
Sweden PMED
Perseus Proteomics Inc. Logo Japan 4882
Pharma Mar S.A. Logo
Develops and commercializes marine-derived oncology treatments for rare cancers.
Spain PHM
Pharmanutra Logo
Develops science-backed nutraceuticals & pharmaceuticals for nutritional & joint health.
Italy PHN
PharmaSGP Holding SE Logo
Develops & distributes natural, pharmacy-exclusive OTC drugs for chronic conditions in Europe.
Germany PSG
Pharmena S.A. Logo
Develops patented 1-MNA molecule for dermocosmetics and supplements in EU & North American markets.
Poland PHR